QTMeds

Drug Database Monograph

ENJAYMO 50 mg/ml

PENDING REVIEW

Active Ingredient: SUTIMLIMAB

QTc Interval Status:

neutral

Clinical Description (Database Summary)

Scientific Sources / References

Analyse RCP (Automatique), id : 69505243

← Back to Prescription Analyzer